News
Trump Administration to Pilot Coverage of Weight‑loss Drugs Under Medicare and Medicaid, Washington Post Reports
U.S. President Donald Trump listens to remarks during a swearing-in ceremony for Administrator of the Centers for Medicare and Medicaid Services Mehmet Oz in the Oval Office in Washington, D.C., U.S., April 18, 2025. REUTERS/Nathan Howard/File Photo
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
Eli Lilly (NYSE:LLY) stock rose 1.3% and Novo Nordisk (NYSE:NVO) shares jumped 2% Friday morning after The Washington Post ...
Trump's legislation will require more Medicaid patients to work. In two states that tried it, many lost coverage.
Throughout the country, pediatricians say anxious parents are concerned about access to routine childhood immunizations, ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback